UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Appetite and body weight regulation after bariatric surgery

Obesity reviews, 2015-02, Vol.16 (S1), p.77-90

2015

Volltextzugriff (PDF)

Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network

European journal of cancer (1990), 2019-08, Vol.117, p.121-130

2019

Volltextzugriff (PDF)

Leptin deficient ob/ob mice and diet-induced obese mice responded differently to Roux-en-Y bypass surgery

International Journal of Obesity, 2015-05, Vol.39 (5), p.798-805

2015

Volltextzugriff (PDF)

Endovascular Thrombectomy in the Elderly: Do Radiological and Clinical Outcomes Differ from Those in Younger Patients? A Prospective Single-Center Experience

Cerebrovascular diseases (Basel, Switzerland), 2019-04, Vol.47 (1-2), p.65-71

2019

Volltextzugriff (PDF)

Development of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus aureus

Journal of Clinical Microbiology, 2005-10, Vol.43 (10), p.5285-5287

2005

Volltextzugriff (PDF)

Myths and facts about getting an academic faculty position in neuroscience

Science advances, 2021-08, Vol.7 (35)

2021

Volltextzugriff (PDF)

How to get from here to there: macrophage recruitment in Alzheimer's disease

Current Alzheimer research, 2011-03, Vol.8 (2), p.156-163

2011

Volltextzugriff (PDF)

Optical quenching and recovery of photoconductivity in single-crystal diamond

Applied physics letters, 2017-01, Vol.110 (1)

2017

Volltextzugriff (PDF)

Are IPL home devices really foolproof?

Journal of the European Academy of Dermatology and Venereology, 2016-05, Vol.30 (5), p.856-857

2016

Volltextzugriff (PDF)

A magnetic trap for high-field seeking neutron spin states

Physics letters. B, 2015-02, Vol.741, p.316-319

2015

Volltextzugriff (PDF)

Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients

British journal of cancer, 2010-08, Vol.103 (4), p.560-566

2010

Volltextzugriff (PDF)

A phase Ib trial with MK-8628/OTX015, a small molecule inhibitor of bromodomain (BRD) and extra-terminal (BET) proteins, in patients with selected advanced solid tumors

European journal of cancer (1990), 2016-12, Vol.69, p.S2-S3

2016

Volltextzugriff (PDF)

Thrombectomy in large vessel occlusion stroke—Does age matter?

Acta neurologica Scandinavica, 2022-11, Vol.146 (5), p.628-634

2022

Volltextzugriff (PDF)

587 Cellular pharmacokinetics and molecular pharmacodynamics studies of the BRD-BET inhibitor OTX015 in sensitive and resistant leukemic cell lines

European journal of cancer (1990), 2014-11, Vol.50, p.189-189

2014

Volltextzugriff (PDF)

469 OTX015, a novel BET-bromodomain (BET-BRD) inhibitor, is a promising anticancer agent for human glioblastoma

European journal of cancer (1990), 2014-11, Vol.50, p.153-153

2014

Volltextzugriff (PDF)

Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain β-amyloid production

Neuroscience, 2006-11, Vol.142 (4), p.941-952

2006

Volltextzugriff (PDF)

431 Real-time pharmacokinetic (PK) results from an ongoing randomized, parallel-dose phase 1 study of onapristone in patients (pts) with progesterone receptor (PR)-expressing cancers

European journal of cancer (1990), 2014-11, Vol.50, p.142-142

2014

Volltextzugriff (PDF)

Schizophrenia and Cognitive Dysmetria: A Positron-Emission Tomography Study of Dysfunctional Prefrontal--Thalamic--Cerebellar Circuitry

Proceedings of the National Academy of Sciences - PNAS, 1996-09, Vol.93 (18), p.9985-9990

1996

Volltextzugriff (PDF)

5LBA Results of a first-in-man phase I trial assessing OTX015, an orally available BET-bromodomain (BRD) inhibitor, in advanced hematologic malignancies

European journal of cancer (1990), 2014-11, Vol.50, p.196-196

2014

Volltextzugriff (PDF)

Endovascular thrombectomy at low‐volume centres: A Bayesian solution

Acta neurologica Scandinavica, 2020-08, Vol.142 (2), p.169-174

2020

Volltextzugriff (PDF)

Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2

British journal of cancer, 2012-02, Vol.106 (4), p.673-677

2012

Volltextzugriff (PDF)

Kikuchi-Fujimoto Disease: Hydroxychloroquine as a Treatment

Clinical infectious diseases, 2004-12, Vol.39 (12), p.e124-e126

2004

Volltextzugriff (PDF)

563 Ex Vivo Culture of Fresh Tumor Tissues From Patients Assessing Pharmacodynamic (PD) Markers of OTX008, a Novel Galectin-1 Inhibitor: Relevance to Phase I Trial

European journal of cancer (1990), 2012-11, Vol.48, p.173-173

2012

Volltextzugriff (PDF)

Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study

The Lancet. Haematology, 2016-04, Vol.3 (4), p.e186-e195

2016

Volltextzugriff (PDF)

Why Don't They Listen? Adherence to Recommendations of Infectious Disease Consultations

Clinical infectious diseases, 2004-05, Vol.38 (9), p.1212-1218

2004

Volltextzugriff (PDF)

1 – 25 von 489

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(404)
Mit Volltextzugriff
(390)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(266)
Life Sciences & Biomedicine
(221)
Humans
(196)
Female
(114)
Biological And Medical Sciences
(100)
Male
(94)
Medical Sciences
(83)
Adult
(81)
Middle Aged
(73)
Neurosciences & Neurology
(63)
Aged
(58)
Clinical Neurology
(51)
Surgery
(40)
Animals
(39)
Technology
(34)
Deep Brain Stimulation
(30)
Neurosurgery
(29)
Engineering
(28)
Magnetic Resonance Imaging
(26)
Radiology, Nuclear Medicine & Medical Imaging
(26)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Appetite and body weight regulation after bariatric surgery

Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network

Leptin deficient ob/ob mice and diet-induced obese mice responded differently to Roux-en-Y bypass surgery

Endovascular Thrombectomy in the Elderly: Do Radiological and Clinical Outcomes Differ from Those in Younger Patients? A Prospective Single-Center Experience

Development of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus aureus

Myths and facts about getting an academic faculty position in neuroscience

How to get from here to there: macrophage recruitment in Alzheimer's disease

Optical quenching and recovery of photoconductivity in single-crystal diamond

Are IPL home devices really foolproof?

A magnetic trap for high-field seeking neutron spin states

Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients

A phase Ib trial with MK-8628/OTX015, a small molecule inhibitor of bromodomain (BRD) and extra-terminal (BET) proteins, in patients with selected advanced solid tumors

Thrombectomy in large vessel occlusion stroke—Does age matter?

587 Cellular pharmacokinetics and molecular pharmacodynamics studies of the BRD-BET inhibitor OTX015 in sensitive and resistant leukemic cell lines

469 OTX015, a novel BET-bromodomain (BET-BRD) inhibitor, is a promising anticancer agent for human glioblastoma

Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain β-amyloid production

431 Real-time pharmacokinetic (PK) results from an ongoing randomized, parallel-dose phase 1 study of onapristone in patients (pts) with progesterone receptor (PR)-expressing cancers

Schizophrenia and Cognitive Dysmetria: A Positron-Emission Tomography Study of Dysfunctional Prefrontal--Thalamic--Cerebellar Circuitry

5LBA Results of a first-in-man phase I trial assessing OTX015, an orally available BET-bromodomain (BRD) inhibitor, in advanced hematologic malignancies

Endovascular thrombectomy at low‐volume centres: A Bayesian solution

Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2

Kikuchi-Fujimoto Disease: Hydroxychloroquine as a Treatment

563 Ex Vivo Culture of Fresh Tumor Tissues From Patients Assessing Pharmacodynamic (PD) Markers of OTX008, a Novel Galectin-1 Inhibitor: Relevance to Phase I Trial

Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study

Why Don't They Listen? Adherence to Recommendations of Infectious Disease Consultations

Suchergebnisse filtern